Observational Registry Study of Chinese Patients Treated With Revlimid (Lenalidomide)
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Yu (Flora) Yao, MD
Celgene Pharmaceutical (Shanghai) Co. Ltd.
Study Director
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
17 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Beijing Hospital
Beijing, China
- Peking Chao-Yang Hospital
Beijing, China
- Peking University People'S Hospital
Beijing, China
- People'S Liberation Army Hospital 307
Beijing, China
- the Fisrt Hospital of Jilin University
Changchun, China
- Xiangya Hospital Central-South University
Changsha, China
- Xinqiao Hospital, 3rd Military Medical University
Chongqing, China
- Nanfang Hospital of China Southern Medical University
Guangzhou, China
- the First Affliated Hospital of Anhui Medical University
Hefei, China
- Qilu Hospital of Shandong University
Jinan, China
- the Affiliated Hospital of Mecical College Qingdao University
Qingdao, China
- Shanghai Changzhen Hospital
Shanghai, China
- the Second Affiliated Hospital of China Medical University
Shenyang, China
- the First Affiliated Hospital of Suzhou University
Suzhou, China
- Tongji Medical College Huazhong University of Science & Technology
Wuhan, China
- Wuhan Union Hospital of Tongji Medical College of Huazhong University of Science & Technology
Wuhan, China
- People'S Hospital of Xinjiang Uygur Autonomous Region
Ürümqi, China
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 30 Nov 2013
- Primary completion
- 31 Jul 2016
- Completion
- 30 Sept 2016
- Last update posted
- 12 Jan 2017
- Registered enrollment
- 176
- Registry id
- NCT01947309
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.